Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome.
During the last decade a battery of animal models used for the study of polycystic ovary syndrome (PCOS) have allowed a focus on different aspects of the pathology. Since dehydroepiandrosterone (DHEA) was found to be one of the most abundant circulating androgens in women with PCOS, a rodent model showing the salient features found in women with PCOS was developed by the injection of DHEA. Although insulin-sensitizing agents, such as biguanides, are clinically used in the treatment of diabetes and PCOS, the complete understanding of their mechanisms of action remains unknown. The present review discusses the molecular mechanisms involved in the development of PCOS by using the DHEA-PCOS murine model and analyzes the role of the biguanide metformin as treatment.
Motta
A B
AB
Laboratorio de Fisio-patología Ovárica, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Facultad de Medicina, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Paraguay 2155, 1121 Buenos Aires, Argentina. aliciabmotta@yahoo.com.ar
D000728:Androgens / Q000008:administration & dosage / Q000378:metabolism; D000818:Animals; D003687:Dehydroepiandrosterone / Q000008:administration & dosage / Q000378:metabolism; D004195:Disease Models, Animal; D020964:Embryo Loss / Q000209:etiology; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D008687:Metformin / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D010060:Ovulation / Q000187:drug effects; D011085:Polycystic Ovary Syndrome / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D011247:Pregnancy; D014599:Uterus / Q000187:drug effects
D000728:Androgens; D007004:Hypoglycemic Agents; D003687:Dehydroepiandrosterone; D008687:Metformin